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Abstract Duchenne’smusculardystrophy (DMD), characterizedbygraduallydevelopingmuscularweakness, leads to
respiratory symptoms andreduced lung function.We aimed to assess lung function in 25 patientswith DMDin relation-
ship to age andmuscular function.The 25 boys, mean age13 years, comprized patients in southern Norway with DMD,
takingpart in an epidemiological follow-up study.Nonehad chronic respiratorydisease.Lung functionwasmeasured by
maximumexpiratory £ow^volumeloops andwhole bodyplethysmography, andrepeated after1year (n=14).Lung func-
tionwasreducedcomparedtopredictedvalues forhealthychildren.Forcedexpiratory volumein1sec (FEV1)% predicted
and forced vital capacity (FVC)% predicted correlated (signi¢cantly) inversely to age.FEV1and FVCdecreased annually
5?61and 4?2% of predicted, respectively. Absolute values of FVC (litres) and FEV1 (l sec
71) increased until mean age14
years, decreasing thereafter.Values in % predicted decreased steadily throughoutthe age range (6^19 years).Lung func-
tion correlated closely to upper limbmuscle function.c 2001Harcourt Publishers Ltd
doi:10.1053/rmed.2001.1177, available online at http://www.idealibrary.comon
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Duchenne’s muscular dystrophy (DMD) is characterized
by a gradually decreasingmuscular strength, a¡ecting all
striated (including the respiratory muscles) and heart
muscle (1). Symptoms present themselves before the
age of 5 years; the main clinical signs being progressive
symmetrical weakness with proximal limb muscles
a¡ected more than distal muscles (2). The progressive
weakness leads to loss of ambulation before the age of
13 years (3) and severe scoliosis (4).
With increasing muscular weakness, a reduction in
lung function occurs (5), and a relationship between pul-
monary function and stage of diseasehasbeen described
(6). The end-stage of the disease is characterized by
increasingly severerespiratorycomplications and cardiac
failure, in combination with severe locomotor problems
(5,7). Measurements of respiratory function are impor-
tant for the evaluation for therapeutic intervention (8)
and the prognosis of the disease (9).
Various aspects of respiratory function have been
assessed in relation to DMD, such as measures of maxi-
mum inspiratory and expiratory pressures to detectReceived 8 February 2001accepted in revised form 21June 2001, and
published online 24 September 2001.
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lium dilution spirometry) (5) and spirometry (3,5). It has
in fact been maintained that forced vital capacity (FVC)
best re£ects clinical status (10).
The primary aim of the present study was to assess
lung function as partof a follow-up studyof childrenwith
DMD in southern Norway, including measures of maxi-
mum expiratory £ow volume-loops and lung volumes.
A secondary objective was to analyse changes in lung
function in relation to the duration of the disease, the
age of the children, and to their physical ability and
muscle function.
METHODSANDSUBJECTS
Design of the study
As part of a major epidemiological follow-up study of
children with DMD in southern Norway (11,12), the 25
boys included in the study underwent lung function test-
ing by use of whole body plethysmograph andmaximum
expiratory £ow-volume loops. A second lung function
measurement was performed after an interval of 1year,
if possible.
The study was approved by the medical ethics com-
mittee, and the parents of the children included in the
study gave informed consent.
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Twenty-¢ve boys with DMD with a median age of 13
years (range 6^19 years) were included into the study.
Fourteen of the subjects underwent a second lung func-
tion measurement after 1 year with a median age of 14
years (range 8^20 years) at the time of the secondmea-
surement. Eleven children could not return for a second
measurementbecause of the strain their long journey to
the hospital (long distances) wouldhave on their physical
condition. Seven subjects (including the oldest boy aged
19 years) used assisted home ventilation (intermittent
positive pressure ventilation via a face mask) during the
night. None of the patients had any chronic lung dis-
orders, and none reported pneumonia in the last year
prior to the investigation. None of the subjects had un-
dergone spinal surgery at the time of investigations.
Methods
Lung function was measured by maximum expiratory
and inspiratory £ow^volume loops and whole body
plethysmograph (Masterlab, Erich Jaeger GmbH & Co
KG,Wˇrzburg,Germany).Calibration of the equipment
was performed daily according to manufacturer’s
instructions. The subjects breathed through a silicon
mouthpiece between the teeth, with a rim inserted
between the teeth and lips, ensuring that no leaks oc-
curred during forced expiration. Measurements were
performed according to recommendations of the Eur-
opean Respiratory Society (13). Forced expiratory vo-
lume during 1sec (FEV1), maximum expiratory £ow at
75, 50 and 25% of remaining vital capacity (MEF75, MEF50
and MEF25), peak expiratory £ow rate (PEF) and forced
vital capacity (FVC) were the lung function parameters
chosen for assessment from the £ow^volume loops. Re-
sistance of the total respiratory system (Rtot), inspira-
tory resistance (Rin), inspiratory vital capacity (VC),
residual volume (RV), total lung capacity (TLC), residual
volume in per cent of total lung capacity (RV/TLC%)
and speci¢c resistance of the respiratory system (SRtot)
(resistance corrected for lung volume) were usedTABLE 1. Demographicdata andmuscular function (Brooke) sc
are given asmeanwith standard deviation (SD) in parenthesis an
Age (years)
Height (cm)
Weight (kg)
Muscular function, upper limbs (Brooke score)
Muscular function, lower limbs (Brooke score)
Age startedwalking (months)
Age stoppedwalking (n=18) (months)for assessment from the body plethysmographmeasure-
ments. Nine subjects were not technically able to per-
form whole body plethysmography, as they were not
able to situnaidedin thepethysmograph.Whenavailable,
results are given as per cent of predicted values (14).
Scoliosis was assessed as mild, moderate and severe
(grade1, 2 and 3, respectively), after clinical examination
and evaluation by an experienced child physiotherapist,
and a neuropaediatrician in co-operation with orthopaedic
surgeons. Radiological assessment was not performed
at the time.
Assessment ofmuscular function
Functional status of the children was assessed using
Brook’s graded scale from 0 to 6 for function of upper
limbs and from 0 to 10 for lower limbs: 0 represented
best function, and a score of 6 and10, respectively, repre-
sented the poorestmuscular function (15).
Statistical analysis
Demographic data are given as mean with standard
deviation (SD) unless otherwise stated. All statistical ana-
lyses were performed by use of Statistical Package for
Social Sciences (SPSS) version 9.0. Bivariate correlation
analyses have been performed employing Pearson’s cor-
relation coe⁄cient. Di¡erences between two groups
were analysed by t-tests, or by ANOVA-test for more
than two samples, if data were normally distributed.
Otherwise data were analysed by the non-parametric
Mann^Whitney U-test for two independent samples or
by the Kruskall^Wallis ANOVA-test for more than two
samples. Di¡erences in categorical variables were com-
pared by the w2-test. All tests were performed with
two tails and a signi¢cance level of 5%.
RESULTS
Demographic data of the 25 boyswith DMD are given in
Table1.The results from lung functionmeasurements areore ofthe 25 boyswithDuchenne’smusculardystrophy.Results
drange
Mean (SD) Range
12?32 (3?69) 6^19
147?7 (20?7) 111^183
44?3 (22?5) 18^99
3?84 (1?55) 1^6
7?16 (2?70) 2^9
18?0 (5?6) 11^36
112?2 (11?7) 96^132
900 RESPIRATORYMEDICINEgiven in Table 2 (maximum expiratory £ow^volume
loops) and Table 3 (whole body plethysmograph). FEV1,
FVC and FEF50 were 32?5, 29?3 and 43?8% predicted
respectively in the oldestpatientrequiring (most) nightly
ventilator support, whereas lung function values in the
further six patients requiring ventilatory support did
not di¡er signi¢cantly from thewhole group.
The lower limbs had poor muscular function; with a
mean score of 7?16, the upper limbs were less a¡ected
(mean score 3?84) (Table 1). All parameters of the
maximum expiratory £ow^volume loop were below
predicted values (14), with the lowest mean values
recorded for FVC (62?35% of predicted), FEV1 (68?55%
of predicted) and MEF75 (69?34% of predicted), as shown
inTable 2.Theparameters thought to represent the func-
tion of peripheral airways were higher: MEF50 were
77?31% of predicted, whereas MEF25 were 88?31%
of predicted.TABLE 2 Lung functionmeasuredbymaximumexpiratory £ow
Values are given asmean (SD) andrange
FVC (l)
FVC % predicted 6
FEV1 (l sec
71) (n=20)
FEV1% predicted (n=20) 6
MEF75 (l sec
71)
MEF75% predicted 6
MEF50 (l sec
71)
MEF50 % predicted 7
MEF25 (l sec
71)
MEF25% predicted 8
MEF75^25 (l sec
71) (n=20)
FIV1 ( l sec
71) n=16
TABLE 3. Lung function measured by whole body plethysmog
measurements
Inspiratorycapacity (IC) % predicted
ITGV% predicted (n=18)
ITGV (l) (n=18)
Residualvolume (RV) % predicted (n=18)
RV (l) (n=18)
Total lungcapacity (TLC) % predicted (n=18)
TLC (l) (n=18)
Vital capacity (inspiratory) (VC) % predicted (n=22)
VC (l) (n=22)
RV TLC (%)(n=18)
Speci¢c resistance ofthe airways (SRtot)Measuredby thewholebodyplethysmograph, inspira-
toryVCwas found to be 65?61% of predictedvalue (Table
3), whereas RV was 148?76% of predicted, resulting in
TLC of 84?85% of predicted. RV/TLC (%) was 39?24%.
ITGV was 97?85% of predicted, whereas inspiratory
capacity (IC) was 74?03% of predicted (Table 3). Speci¢c
resistance of the airways, SRtot, was1?025.
Lung function parameters dependent upon a maxi-
mum inspiratory and expiratory manoeuvres decreased
with increasing age. A signi¢cant negative correlation
was found between FEV1and age (r =70?76,P50?001).
By regression analysis it was found that FEV1 in % pre-
dicted decreased by 5?61% per year (Fig.1). FVC also had
a signi¢cant negative correlation with age (r = 70?70,
P50?001), and FVC in % predicted decreased by 4?2%
per year.MEF75,MEF50 and MEF25 in % predicted did not
correlate signi¢cantly with age. Inspiratory VC in % pre-
dicted correlated negatively with age (r = 70?59,volumeloopsin 25 boyswithDuchenne’smusculardystrophy.
Mean (SD) Range
1?69 (0?47) 0?86^2?6
2?35 (22?24) 28?6^123?0
1?64 (0?39) 0?88^2?6
8?55 (23?29) 31?5^113?0
3?21 (1?31) 1?36^6?90
9?34 (19?67) 32?8^114?0
2?50 (1?04) 1?02-5?94
7?31 (25?13) 37?2^136?0
1?41 (0?67) 0?64^3?15
8?31 (42?69) 32?6^203
3?21(1?31) 1?36^6?90
1?53 (0?33) 0?92^2?00
raph.Only 16 patients succeeded technically in performing all
Mean (SD) Range
74?03 (17?78) 41^106
97?85 (30?35) 62?7^160?0
1?71 (0?79) 0?63^3?52
148?76 (60?84) 68?8^256?0
1?26 (0?72) 0?42^2?95
84?85 (17?61) 61?3^122?0
3?04 (1?01) 1?51^5?62
65?61 (14?53) 42?^ 87?1
1?71 (0?50) 0?77^2?73
39?24 (11?85) 17?4^57?4
1?025 (0?273) 0?64^1?63
TABLE 4. Lung functioninthepatientsmeasuredtwicewith anintervalof1year.Thenumberofpatients succeeding technically
inmeasuring theparticularlung functionparameterisgivenforeachparameter.Lung functionis shownaspercentofpredicted.
Values are given asmeanvalueswith 95% con¢dence intervals in parentheses
Measurement1 Measurement 2
Age (years) 12?7 (10?6^14?9) 13?8 (11?6^16?0)
FVC, % pred. (n=14) 61?3 (45?5^77?2) 57?0 (40?8^73?2)
FEV1, % pred. (n=10) 70?2 (51?9^88?6) 65?4 (44?4^86?4)
MEF75, % pred. (n=14) 63?0 (52?8^73?1) 65?5 (56?4^74?5)
MEF50, % pred. (n=14) 69?1 (56?9^81?3) 67?7 (56?4^79?0)
MEF25, % pred. (n=14) 74?3 (55?9^92?8) 71?8 (54?0^89?6)
FIG. 1. Scatterplot of FEV1% predicted versus age. FEV1% pre-
dicted demonstrated a signi¢cant negative correlationwith age
(r =70?76, P5 0?001). FEV1% predicted decreased with 5.61%
per year.
FIG. 2. Scatterplotof FEV1 (l sec
71) versus age.
LUNGFUNCTIONINCHILDRENWITHDMD 901P50?01), whereas IC did not correlate with age. SRtot,
ITGV% predicted, RV%TLC, TLC% predicted and RV%
predicted did not correlate signi¢cantly with age.
FEV1 (l sec
71) and FVC (litres) increased up to an age
of14 years, thereafter a decrease in absolute values was
found, as seen from Fig. 2 for FEV1.
Muscle function score in the upper limbs correlated
signi¢cantly negatively with FEV1% predicted (r =
70?70, P5 0?001), FVC% predicted (r = 70?69,
P5 0?001), as well as inspiratory VC in % predicted (r =
70?58, P7 0?01). MEF75, MEF50, MEF25 in % predicted,
SRtot, ITGV% predicted, RV%TLC, TLC% predicted and
RV% predicted did not correlate signi¢cantly with upper
limb muscular score. Although to a lesser extent, also
lower limb muscular score correlated signi¢cantly nega-
tively with FEV1%predicted (r=70?46,P=0?02), aswellas FVC% predicted (r = 70?49, P7 0?01). A negative
correlation on the border of signi¢cance (r=70?42, P
= 0?06) was found between inspiratory VC% predicted
and lower limb muscle score. The other lung function
parameters did not correlate signi¢cantly with lower
limbmuscular function score.
Scoliosis correlated signi¢cantly with FVC% predicted
and FEV1% predicted (r=70?54, P=0?006 and
r=70?58,P=0?008, respectively).
In the 14 boys measured twice with an interval of 1
year, all parameters of the maximum expiratory £ow^
volume loop decreased, but not signi¢cantly.Too few of
the patientsmanaged to performwhole body plethysmo-
graphy twice for statistical analyses. Mean di¡erence in
IVC and FVCwas 0?006 l (0?23 l SD).
DISCUSSION
Lung function measured by maximum expiratory £ow^
volume loops was below predicted values for all
902 RESPIRATORYMEDICINEparameters. Itwas found that theparameters decreased
with increasing age, and in particular with decreasing
muscular function in the upper limbs and lower limbs as
assessed by Brooke’s score (15). Lung function para-
meters requiring a maximum inspiratory e¡ort were
lower compared to predicted values than lung function
measurements not dependent upon a maximum inspira-
tory e¡ort such as MEF50 and MEF25 (Table 2).
Whereas FEV1 and FVC corrected for height, weight
and age (% predicted) showed a steady decrease
throughout the age range, FEV1 and FVC in absolute
values increased up to an age of 14 years, thereafter
decreasing (Fig. 2 for FEV1).Up to this age, growth seems
to some extent to outweigh the reduction observed in
FEV1 and FVC corrected for age, height and weight.
However, from this age, growth does not compensate
for the decline in lung function due to decreasingmuscu-
lar function.This is in agreement with the observations
by Brooke et al. (16).
At re-investigation after 1 year, lung function mea-
sured by £ow^volume loops decreased, but not signi¢-
cantly, in 14 patients, possibly due to the short
observation time span.
It has been maintained that patients with neuromus-
cular diseases demonstrate reductions in £ow rates
which parallel the decreases in lung volumes (17,18).This
is in agreement with our ¢ndings for FVC, FEV1 and
MEF75, but not for MEF25 and MEF50. It is generally re-
garded that MEF50 and MEF25 are sensitive to changes in
peripheral airways size, whereas FEV1, MEF75, and FVC
are thought to re£ect the state of the greater, central
airways. FEV1and lung volumes such as FVC and VC de-
pend upon a full inspiration, requiring muscular force toFIG. 3. Scatterplot of FEV1 % predicted versus upper limbs
muscular function score. The score increased with decreasing
muscular function. FEV1% predicted demonstrated a signi¢cant
negative correlation with upper limbs muscular function score
(r =70?70, P5 0?001).obtain optimal values. This is supported by our ¢ndings
of a signi¢cant correlation between limbmuscle function
and FVC and FEV1 (Fig. 3).The relationship between FVC
and manual muscle test score has previously been de-
scribed by McDonald et al. (1). Griggs maintained that
FVC is themostuseful pulmonary function test formon-
itoring disease progression, as it is precise and reprodu-
cible, although less sensitive to detect muscle weakness
than are maximial inspiratory and expiratory pressures
(19).This was also con¢rmed by Hahn et al. who demon-
strated that lung volume changes in patients with DMD
correlatedwith respiratorymuscleweakness (5).On the
other hand, parameters, which are commonly regarded
as measures of peripheral airways function (such as
MEF25 and MEF50), may in patients with neuromuscular
diseases possibly better re£ect the state of the airways
and the lungs, taking into consideration thepatient’s abil-
ity to generate su⁄cient £ow through the peripheral
airways.
A statistically signi¢cant negative correlation was
foundbetween lung function (FEV1%predicted) andmus-
cular function score of the upper limbs (Fig. 3), whereas
this was not found for the lower limbs.This may be due
to the close anatomical relationshipbetween themuscles
of the upper limbs and the respiratory muscles, as the
muscles of the lower limbs are more severely a¡ected
at an early stage of the disease than the muscles of the
upper limbs and the trunk. There was also a signi¢cant
inverse relationship between clinical grading of scolisis
and lung function in per cent predicted, in the present
study. There are con£icting data on the e¡ect of spinal
stabilisation and pulmonary function. Galasko demon-
strated that spinal stabilization reduced the annual de-
cline of lung function in patients with DMD (20).On the
other hand, Miller found no di¡erence in the rate of de-
terioration of the percentage of normal FVC after spinal
fusion in a group of 21children compared to 46 non-fused
DMD su¡erers (21). Kennedy in a later study found that
spinal stabilization in DMD did not alter the decline in
pulmonary function, nor did it improve survival (22).
Spinal surgery was refusedby the subjects in the present
study, thus no such assessment could be performed.
The decline in FEV1 and FVC (% predicted) with age
(Fig. 1) and the lack of correlation between MEF50 and
MEF25 (% predicted) and age is a further support that
the former parameters more closely re£ect the decline
inmuscular function.
The mean di¡erence between inspiratory and expira-
tory forced capacity was very small (0?006 l), suggesting
that the subjects had su⁄cient muscular strength to
empty their lungs during forced expiratory manouvre,
thus justifying the interpretation of peripheral lung func-
tion values.
In conclusion,we found that lung functionmeasured in
boys with DMD by £ow^volume loops and whole body
plethysmography decreased with increasing age and
LUNGFUNCTIONINCHILDRENWITHDMD 903particularly FVC and FEV1 in % predicted values re-
£ected themuscle function of the upper limbs.
Measurements of £ow volume loops may be of parti-
cular value in the clinical follow-up of patientswithDMD
as they may assist in the evaluation of both the assess-
ment of muscular function as well as the state of the
respiratory tract.
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